The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Inovio Pharmaceuticals, Inc. (NASDAQ: INO) who purchased shares between February 14, 2020 and March 9, 2020. The action, which was filed in the United States District Court for the Eastern District of Pennsylvania, alleges that the Company violated federal securities laws.
In particular, the Inovio lawsuit alleges that defendants made misleading statements about the company’s development of a purported vaccine for the novel coronavirus, artificially inflating the company’s share price and resulting in significant investor losses.
Shareholders have until May 12, 2020 to petition the court for lead plaintiff status. Your ability to share in any recovery does not require that you serve as lead plaintiff. You may choose to be an absent class member.
To learn more and keep informed, complete this form >